- DoubleVerify Holdings, Inc DV prepared to replace Meridian Bioscience Inc VIVO in the S&P SmallCap 600 effective before the opening of trading on January 31.
- SD Biosensor will acquire Meridian Bioscience in a deal likely to be completed soon.
- Last November, DoubleVerify selling shareholders raised $264 million via a secondary equity offering of 10 million shares at $26.40 per share.
- The offer price implied a 6.85% premium to DoubleVerify's November 9 closing of $24.71.
- Price Action: DV shares traded higher by 9.67% at $27.82 on the last check Thursday.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
